P. Feldblum, A. Adeiga, R. Bakare, S. Wevill, A. Lendvay et al., SAVVY Vaginal Gel (C31G) for Prevention of HIV Infection: A Randomized Controlled Trial in Nigeria, PLoS ONE, vol.339, issue.1, p.1474, 2008.
DOI : 10.1371/journal.pone.0001474.s002

L. Van-damme, R. Govinden, F. Mirembe, F. Guedou, S. Solomon et al., Lack of Effectiveness of Cellulose Sulfate Gel for the Prevention of Vaginal HIV Transmission, New England Journal of Medicine, vol.359, issue.5, pp.359463-472, 2008.
DOI : 10.1056/NEJMoa0707957

H. Saidi, M. Jenabian, and L. Bélec, Early events in vaginal HIV transmission: implications in microbicide development, Future Virology, vol.4, issue.3, pp.259-269, 2009.
DOI : 10.2217/fvl.09.10

H. Ying, J. X. Hart, M. Gupta, K. Saifuddin, M. Zariffard et al., Interaction of Mannose-Binding Lectin with HIV Type 1 Is Sufficient for Virus Opsonization But Not Neutralization, AIDS Research and Human Retroviruses, vol.20, issue.3, pp.327-335, 2004.
DOI : 10.1089/088922204322996563

R. Royce, A. Sena, W. Cates, . Jr, and M. Cohen, Sexual Transmission of HIV, New England Journal of Medicine, vol.336, issue.15, pp.1072-1078, 1997.
DOI : 10.1056/NEJM199704103361507

R. Shepard, J. Schock, K. Robertson, D. Shugars, J. Dyer et al., Quantitation of human immunodeficiency virus type 1 RNA in different biological compartments, Journal of clinical microbiology, vol.38, issue.4, pp.1414-1418, 2000.

A. Neurath, N. Strick, and Y. Li, Role of seminal plasma in the anti-HIV-1 activity of candidate microbicides, BMC Infectious Diseases, vol.7, issue.1, p.150, 2006.
DOI : 10.1042/bj2360097

H. Stoiber, C. Speth, and M. Dierich, Role of complement in the control of HIV dynamics and pathogenesis, Vaccine, vol.21, issue.2, pp.77-82, 2003.
DOI : 10.1016/S0264-410X(03)00203-2

A. Rahimi, H. Sepehri, J. Pakravesh, and K. Bahar, Quantification of C3 and C4 in Infertile Men with Antisperm Antibody in Their Seminal Plasma, American Journal of Reproductive Immunology, vol.22, issue.1, pp.330-336, 1999.
DOI : 10.1111/j.1600-0897.1999.tb00446.x

H. Stoiber, Z. Banki, D. Wilflingseder, and M. Dierich, Complement???HIV interactions during all steps of viral pathogenesis, Vaccine, vol.26, issue.24, pp.3046-3054, 2008.
DOI : 10.1016/j.vaccine.2007.12.003

O. Vanderpuye, C. Labarrere, and J. Mcintyre, The Complement System in Human Reproduction, American Journal of Reproductive Immunology, vol.173, issue.3-4, pp.3-4145, 1992.
DOI : 10.1111/j.1600-0897.1992.tb00742.x

H. Bouhlal, N. Chomont, N. Haeffner-cavaillon, M. Kazatchkine, L. Belec et al., Opsonization of HIV-1 by Semen Complement Enhances Infection of Human Epithelial Cells, The Journal of Immunology, vol.169, issue.6, pp.3301-3306, 2002.
DOI : 10.4049/jimmunol.169.6.3301

H. Bouhlal, N. Chomont, M. Requena, N. Nasreddine, H. Saidi et al., Opsonization of HIV with Complement Enhances Infection of Dendritic Cells and Viral Transfer to CD4 T Cells in a CR3 and DC-SIGN-Dependent Manner, The Journal of Immunology, vol.178, issue.2, pp.1086-1095, 2007.
DOI : 10.4049/jimmunol.178.2.1086

H. Saidi, J. Eslahpazir, C. Carbonneil, L. Carthagena, M. Requena et al., Differential modulation of human lactoferrin activity against both R5 and X4-HIV-1 adsorption on epithelial cells and dendritic cells by natural antibodies, J Immunol, issue.8, pp.1775540-5549, 2006.

J. Ball, Z. Moldoveanu, L. Melsen, P. Kozlowski, S. Jackson et al., Compans RW: A polarized human endometrial cell line that binds and transports polymeric IgA, In vitro cellular & developmental biology, issue.3, pp.31196-206, 1995.

E. Van-damme and W. Peumans, Related mannose-specific lectins from different species of the family Amaryllidaceae, Physiologia Plantarum, vol.85, issue.1, pp.52-57, 1988.
DOI : 10.1016/0014-5793(87)80129-1

M. Baba, D. Schols, D. Clercq, E. Pauwels, R. Nagy et al., Novel sulfated polymers as highly potent and selective inhibitors of human immunodeficiency virus replication and giant cell formation., Antimicrobial Agents and Chemotherapy, vol.34, issue.1, pp.134-138, 1990.
DOI : 10.1128/AAC.34.1.134

B. Berkhout, R. Floris, I. Recio, and S. Visser, The antiviral activity of the milk protein lactoferrin against the human immunodeficiency virus type??1, BioMetals, vol.17, issue.3, pp.291-294, 2004.
DOI : 10.1023/B:BIOM.0000027707.82911.be

K. Vermeire, J. Brouwers, Y. Van-herrewege, L. Grand, R. Vanham et al., CADA, a Potential Anti-HIV Microbicide that Specifically Targets the Cellular CD4 Receptor, Current HIV Research, vol.6, issue.3, pp.246-256, 2008.
DOI : 10.2174/157016208784324958

H. Bouhlal, J. Galon, M. Kazatchkine, W. Fridman, and C. Sautes-fridman, Soluble CD16 Inhibits CR3 (CD11b/CD18)-Mediated Infection of Monocytes/Macrophages by Opsonized Primary R5 HIV-1, The Journal of Immunology, vol.166, issue.5, pp.3377-3383, 2001.
DOI : 10.4049/jimmunol.166.5.3377

H. Hocini, P. Becquart, H. Bouhlal, N. Chomont, P. Ancuta et al., Active and Selective Transcytosis of Cell-Free Human Immunodeficiency Virus through a Tight Polarized Monolayer of Human Endometrial Cells, Journal of Virology, vol.75, issue.11, pp.755370-5374, 2001.
DOI : 10.1128/JVI.75.11.5370-5374.2001

H. Stoiber, I. Frank, M. Spruth, M. Schwendinger, B. Mullauer et al., Inhibition of HIV-1 infection in vitro by monoclonal antibodies to the complement receptor type 3 (CR3): an accessory role for CR3 during virus entry? Molecular immunology, pp.12-13855, 1997.

N. Thieblemont, C. Delibrias, E. Fischer, L. Weiss, and M. Kazatchkine, Complement enhancement of HIV infection is mediated by complement receptors, Immunopharmacology, vol.25, issue.2, pp.87-93, 1993.
DOI : 10.1016/0162-3109(93)90012-F

Z. Banki, H. Stoiber, and M. Dierich, HIV and human complement: inefficient virolysis and effective adherence, Immunology Letters, vol.97, issue.2, pp.209-214, 2005.
DOI : 10.1016/j.imlet.2004.11.007

C. Pinter, A. Siccardi, L. Lopalco, R. Longhi, and A. Clivio, HIV Glycoprotein 41 and Complement Factor H Interact with Each Other and Share Functional as Well as Antigenic Homology, AIDS Research and Human Retroviruses, vol.11, issue.8, pp.11971-980, 1995.
DOI : 10.1089/aid.1995.11.971

J. Schmitz, J. Zimmer, B. Kluxen, S. Aries, M. Bogel et al., Antibody-dependent complement-mediated cytotoxicity in sera from patients with HIV-1 infection is controlled by CD55 and CD59., Journal of Clinical Investigation, vol.96, issue.3, pp.961520-1526, 1995.
DOI : 10.1172/JCI118190

H. Stoiber, C. Ammann, M. Spruth, B. Mullauer, A. Eberhart et al., Enhancement of Complement-Mediated Lysis by a Peptide Derived from SCR 13 of Complement Factor H, Immunobiology, vol.203, issue.4, pp.670-686, 2001.
DOI : 10.1016/S0171-2985(01)80016-4

H. Stoiber, C. Pinter, A. Siccardi, A. Clivio, and M. Dierich, Efficient destruction of human immunodeficiency virus in human serum by inhibiting the protective action of complement factor H and decay accelerating factor (DAF, CD55) The Journal of experimental medicine, pp.307-310, 1996.

D. Takefman, B. Sullivan, B. Sha, and G. Spear, Mechanisms of Resistance of HIV-1 Primary Isolates to Complement-Mediated Lysis, Virology, vol.246, issue.2, pp.370-378, 1998.
DOI : 10.1006/viro.1998.9205

A. Stone, Microbicides: a new approach to preventing HIV and other sexually transmitted infections, Nature Reviews Drug Discovery, vol.62, issue.12, pp.977-985, 2002.
DOI : 10.1038/nrd959

J. Balzarini, Targeting the glycans of glycoproteins: a novel paradigm for antiviral therapy, Nature Reviews Microbiology, vol.33, issue.8, pp.583-597, 2007.
DOI : 10.1038/nrmicro1707

J. Balzarini, S. Hatse, K. Vermeire, K. Princen, S. Aquaro et al., Mannose-Specific Plant Lectins from the Amaryllidaceae Family Qualify as Efficient Microbicides for Prevention of Human Immunodeficiency Virus Infection, Antimicrobial Agents and Chemotherapy, vol.48, issue.10, pp.483858-3870, 2004.
DOI : 10.1128/AAC.48.10.3858-3870.2004

H. Saidi, G. Magri, N. Nasreddine, M. Requena, and L. Belec, R5- and X4-HIV-1 use differentially the endometrial epithelial cells HEC-1A to ensure their own spread: Implication for mechanisms of sexual transmission, Virology, vol.358, issue.1, pp.55-68, 2007.
DOI : 10.1016/j.virol.2006.07.029

R. Vives, A. Imberty, Q. Sattentau, and H. Lortat-jacob, Heparan sulfate targets the HIV-1 envelope glycoprotein gp120 coreceptor binding site. The Journal of biological chemistry, pp.21353-21357, 2005.

R. June, S. Schade, M. Bankowski, M. Kuhns, A. Mcnamara et al., Complement and antibody mediate enhancement of HIV infection by increasing virus binding and provirus formation, AIDS, vol.5, issue.3, pp.269-274, 1991.
DOI : 10.1097/00002030-199103000-00004

T. Geijtenbeek, D. Kwon, R. Torensma, S. Van-vliet, G. Van-duijnhoven et al., DC-SIGN, a Dendritic Cell???Specific HIV-1-Binding Protein that Enhances trans-Infection of T Cells, Cell, vol.100, issue.5, pp.587-597, 2000.
DOI : 10.1016/S0092-8674(00)80694-7

M. Requena, H. Bouhlal, N. Nasreddine, H. Saidi, J. Gody et al., T lymphocytes by natural antibodies to the CRD domain of DC-SIGN purified from breast milk and intravenous immunoglobulins, Immunology, vol.164, issue.4, pp.508-518, 2008.
DOI : 10.1128/JVI.78.20.10848-10855.2004

H. Saidi, G. Magri, C. Carbonneil, N. Nasreddine, M. Requena et al., >IFNgamma-activated monocytes weakly produce HIV-1 but induce the recruitment of HIV-sensitive T cells and enhance the viral production by these recruited T cells, Journal of leukocyte biology, issue.3, pp.81642-653, 2007.

D. Legrand, K. Vigie, E. Said, E. Elass, M. Masson et al., Surface nucleolin participates in both the binding and endocytosis of lactoferrin in target cells, European Journal of Biochemistry, vol.84, issue.2, pp.271303-317, 2004.
DOI : 10.1023/A:1026205603217
URL : https://hal.archives-ouvertes.fr/hal-00104916

S. Nisole, E. Said, C. Mische, M. Prevost, B. Krust et al., The anti-HIV pentameric pseudopeptide HB-19 binds the C-terminal end of nucleolin and prevents anchorage of virus particles in the plasma membrane of target cells. The Journal of biological chemistry, pp.27720877-20886, 2002.

L. Margolis and R. Shattock, Selective transmission of CCR5-utilizing HIV-1: the 'gatekeeper' problem resolved?, Nature Reviews Microbiology, vol.11, issue.4, pp.312-317, 2006.
DOI : 10.1038/nrmicro1387

. Jenabian, Differential activity of candidate microbicides against early steps of HIV-1 infection upon complement virus opsonization AIDS Research and Therapy, p.16, 2010.